Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology.

Levine GN, D'Amico AV, Berger P, Clark PE, Eckel RH, Keating NL, Milani RV, Sagalowsky AI, Smith MR, Zakai N, American Heart Association Council on Clinical Cardiology and Council on Epidemiology and Prevention, the American Cancer Society, and the American Urological Association
Circulation. 2010 121 (6): 833-40

PMID: 20124128 · PMCID: PMC3023973 · DOI:10.1161/CIRCULATIONAHA.109.192695

MeSH Terms (12)

Advisory Committees American Cancer Society American Heart Association Androgen Antagonists Cardiovascular Diseases Gonadotropin-Releasing Hormone Humans Male Prostatic Neoplasms Risk Factors Societies, Medical United States

Connections (1)

This publication is referenced by other Labnodes entities: